查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1617847

感染控制市场：按传播方式、产品和最终用户划分 - 2025-2030 年全球预测

Infection Control Market by Transmission (Airborne, Bloodborne, Contract), Products (Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年感染控制市场价值为436.2亿美元，预计到2024年将达到457.9亿美元，复合年增长率为5.23%，到2030年将达到623.6亿美元。

感染控制包括旨在减少感染传播的各种政策和程序，特别是在医疗机构中，以保护患者和医护人员。其范围从医院和诊所延伸到社区健康和住宅护理设施等其他场所，使其成为医疗保健服务的重要方面。在 COVID-19 大流行期间，透过加强手部卫生、消毒、疫苗接种和使用个人防护工具等措施，控制感染的必要性变得更加明显。研究应用涵盖各种最终用途部门，包括医院、门诊手术中心和实验室。全球感染控制市场的主要成长决定因素包括医疗保健相关感染（HAI）盛行率的上升、灭菌和消毒技术的进步、感染预防意识的提高和政府倡议以及老年护理服务，其中包括老年人口的增加。存在巨大的商机，包括对一次性医用不织布、智慧感染控制管理系统的需求激增，以及提供相关感染控制建议的远端医疗服务的扩展。然而，该市场面临一些挑战，例如实施先进感染控制系统的高成本、不同地区的监管要求以及缺乏训练有素的专业人员（尤其是在新兴国家）。专注于抗菌涂层仪器、自动灭菌系统和用于感染风险评估的资料驱动预测分析的创新可能会推动业务的显着成长。目前，在公共卫生紧迫性和技术创新的推动下，市场充满活力，但随着世界对感染预防意识的增强，竞争也越来越严重。利用技术改进，同时解决成本和培训限制，可以为感染控制解决方案的有效性和可近性带来正面的结果。对于策略性业务运营，与将人工智慧和物联网整合到感染预防和控制中的科技公司合作可以提供竞争优势。

主要市场统计
基准年[2023] 436.2亿美元
预计年份 [2024] 457.9亿美元
预测年份 [2030] 623.6亿美元
复合年增长率（%） 5.23%

市场动态：揭示快速发展的感染控制市场的关键市场洞察

供需的动态交互作用正在改变感染控制市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 医院感染发生率上升和感染控制产品的快速使用
    • 手术数量的增加以及对适当安全方法的需求
    • 感染控制产品在医疗设备和製药业的快速采用
  • 市场限制因素
    • 与化学消毒剂相关的副作用
  • 市场机会
    • 医院和诊所增加灭菌服务外包
    • 製造商增加生产感染控制产品的投资
  • 市场挑战
    • 感染控制替代产品和技术的可用性

波特五力：驾驭感染控制市场的策略工具

波特的五力框架是了解感染控制市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解感染控制市场的外部影响

外部宏观环境因素在塑造感染控制市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解感染控制市场的竞争格局

对感染控制市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵感染控制市场供应商的绩效评估

FPNV 定位矩阵是评估感染控制市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了感染控制市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，感染控制市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5.产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 医院感染发生率上升和感染控制产品的快速使用
      • 外科手术的增加和采取适当安全措施的必要性
      • 感染控制产品在医疗设备和製药业的快速采用
    • 抑制因素
      • 与化学消毒剂相关的副作用
    • 机会
      • 医院和诊所增加灭菌服务外包
      • 製造商增加感染控制产品生产的投资
    • 任务
      • 替代感染控制产品和技术的可用性
  • 市场区隔分析
    • 产品：灭菌的使用正在迅速增加，以通过去除包括孢子在内的所有形式的微生物来确保医疗设备的安全。
    • 最终使用者：不断发展医院和诊所部门感染控制的使用
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 感染控制市场传播

  • 空气
  • 血源性的
  • 合约

第七章感染控制市场：副产品

  • 清洁消毒
    • 消毒剂
      • 干洗手剂
      • 器械消毒剂
      • 皮肤消毒剂
      • 表面消毒剂
    • 装置
      • 闪光消毒装置
      • 超音波清洗机
      • 紫外线消毒器
      • 清洗消毒机
    • 处方
      • 消毒喷雾
      • 消毒纸巾
      • 液体消毒剂
    • 消毒等级
      • 进阶
      • 中级
      • 低级
  • 内视镜再处理
    • 消耗品
    • 装置
  • 防护屏障
    • 盖和封闭
    • 风镜
    • 医用不织布
  • 消毒
    • 电子束灭菌
    • 设备灭菌
    • 环氧乙烷灭菌
    • 过滤除菌
    • 伽玛射线灭菌
    • 放射线杀菌
    • 蒸气灭菌

第八章感染控制市场：依最终用户分类

  • 食品和饮料公司
  • 医院/诊所
  • 生命科学产业
  • 医疗设备公司
  • 製药公司

第九章美洲感染控制市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太感染控制市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲感染控制市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 科德宝医疗在哥斯大黎加建立第二个生产工厂
    • WPT 非织造布公司在肯塔基州製造工厂投资 1,950 万美元，以促进当地经济
    • Berry 推出了轻型管封闭解决方案，符合感染控制通讯协定规定的严格安全和卫生标准。
  • 战略分析和建议

公司名单

  • 3M Company
  • Abbott Laboratories
  • AliMed, Inc.
  • Amway Corporation
  • Ansell Ltd.
  • ASP International GmbH
  • Becton, Dickinson and Company
  • Belimed AG
  • bioMerieux SA
  • Cantel Medical Group
  • Cardinal Health Inc.
  • Codi Group BV
  • Colgate-Palmolive Company
  • Dandong Huayang Textile and Garment Co., Ltd.
  • Diversey Holdings Ltd.
  • Ecolab Corporation
  • Embuer Health Pvt. Ltd.
  • Essity AB
  • F. Hoffmann-La Roche Ltd.
  • Getinge AB
  • Go Green Solutions, LLC
  • GOJO Industries, Inc.
  • Hartmann Group
  • Jiaxing Hongjie Commodity Co., Ltd.
  • Kao Corporation
  • Kimberly-Clark Corporation
  • Matachana Group
  • Medexter Healthcare GmbH
  • Medline Industries, LP
  • MELAG Medizintechnik GmbH & Co. KG
  • Merck KGaA
  • Metrex Research, LLC
  • Nice-Pak Products, Inc.
  • Olympus Corporation
  • Pal International Ltd.
  • Pfizer Inc.
  • Procter & Gamble Company
  • Professional Disposables International, Inc.
  • Reckitt Benckiser Group PLC
  • Rockline Industries Ltd.
  • SC Johnson & Son, Inc.
  • Sotera Health LLC
  • Sterigenics International LLC
  • Steris Corporation
  • Unicharm Corporation
  • Unilever PLC
  • Weiman Products, LLC
  • World Precision Instruments, LLC
  • Yessor Wipes
Product Code: MRR-43676CF42B0E

The Infection Control Market was valued at USD 43.62 billion in 2023, expected to reach USD 45.79 billion in 2024, and is projected to grow at a CAGR of 5.23%, to USD 62.36 billion by 2030.

Infection control encompasses a range of policies and procedures aimed at inhibiting the spread of infections, especially in healthcare facilities, to protect both patients and healthcare workers. It's a critical dimension of healthcare services, with its scope extending from hospitals and clinics to other environments like community healthcare and residential care facilities. The necessity of infection control became even more pronounced during the COVID-19 pandemic, reinforcing practices like hand hygiene, sterilization, vaccination, and the use of personal protective equipment. Applications span across diverse end-use sectors, including hospitals, ambulatory surgical centers, research laboratories, and more. Key growth determinants for the global infection control market include the rising prevalence of healthcare-associated infections (HAIs), advancements in sterilization and disinfection technologies, heightened awareness and governmental initiatives for infection prevention, and an increased elderly population requiring aged care services. There are significant opportunities such as the surge in demand for single-use medical nonwovens, smart infection control management systems, and the expansion of telemedicine services that offer curated infection control advice. However, the market faces challenges like high costs related to implementing advanced infection control systems, variations in regulatory requirements across regions, and an inadequate number of trained professionals, particularly in developing countries. Innovations concentrated on antimicrobial-coated devices, automated sterilization systems, and data-driven predictive analytics for infection risk assessment could catalyze substantial business growth. The market is currently dynamic, being driven by both public health urgencies and technological innovations, but competition is intensifying as global awareness about infection prevention amplifies. Addressing limitations related to cost and training while capitalizing on technology enhancements can yield positive outcomes in both efficacy and accessibility of infection control solutions. For strategic business maneuvers, collaboration with tech companies to integrate AI and IoT in infection prevention and control may offer competitive advantages.

KEY MARKET STATISTICS
Base Year [2023] USD 43.62 billion
Estimated Year [2024] USD 45.79 billion
Forecast Year [2030] USD 62.36 billion
CAGR (%) 5.23%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Infection Control Market

The Infection Control Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising incidence of hospital-acquired infections and surging usage of infection control products
    • Increasing number of surgical procedures and need for appropriate safety methods
    • Upsurging adoption of infection control products in medical device and pharmaceutical industry
  • Market Restraints
    • Adverse effects associated with chemical based disinfectants
  • Market Opportunities
    • Increasing outsourcing of sterilization services by hospitals, and clinics
    • Growing investments by manufacturers in the production of infection control products
  • Market Challenges
    • Availability of substitute products and techniques for infection control

Porter's Five Forces: A Strategic Tool for Navigating the Infection Control Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Infection Control Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Infection Control Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Infection Control Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Infection Control Market

A detailed market share analysis in the Infection Control Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Infection Control Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Infection Control Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Infection Control Market

A strategic analysis of the Infection Control Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, AliMed, Inc., Amway Corporation, Ansell Ltd., ASP International GmbH, Becton, Dickinson and Company, Belimed AG, bioMerieux SA, Cantel Medical Group, Cardinal Health Inc., Codi Group BV, Colgate-Palmolive Company, Dandong Huayang Textile and Garment Co., Ltd., Diversey Holdings Ltd., Ecolab Corporation, Embuer Health Pvt. Ltd., Essity AB, F. Hoffmann-La Roche Ltd., Getinge AB, Go Green Solutions, LLC, GOJO Industries, Inc., Hartmann Group, Jiaxing Hongjie Commodity Co., Ltd., Kao Corporation, Kimberly-Clark Corporation, Matachana Group, Medexter Healthcare GmbH, Medline Industries, LP, MELAG Medizintechnik GmbH & Co. KG, Merck KGaA, Metrex Research, LLC, Nice-Pak Products, Inc., Olympus Corporation, Pal International Ltd., Pfizer Inc., Procter & Gamble Company, Professional Disposables International, Inc., Reckitt Benckiser Group PLC, Rockline Industries Ltd., S. C. Johnson & Son, Inc., Sotera Health LLC, Sterigenics International LLC, Steris Corporation, Unicharm Corporation, Unilever PLC, Weiman Products, LLC, World Precision Instruments, LLC, and Yessor Wipes.

Market Segmentation & Coverage

This research report categorizes the Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Transmission, market is studied across Airborne, Bloodborne, and Contract.
  • Based on Products, market is studied across Cleaning & Disinfection, Endoscope Reprocessing, Protective Barriers, and Sterilization. The Cleaning & Disinfection is further studied across Disinfectants, Equipment, Formulation, and Level of Disinfection. The Disinfectants is further studied across Hand Disinfectants, Instrument Disinfectants, Skin Disinfectants, and Surface Disinfectants. The Equipment is further studied across Flusher Disinfectors, Ultrasonic Cleaners, UV-Ray Disinfectors, and Washer Disinfectors. The Formulation is further studied across Disinfectant Sprays, Disinfectant Wipes, and Liquid Disinfectants. The Level of Disinfection is further studied across High-Level, Intermediate-Level, and Low-Level. The Endoscope Reprocessing is further studied across Consumables and Equipment. The Protective Barriers is further studied across Covers & Closures, Goggles, and Medical Nonwovens. The Sterilization is further studied across E-Beam Sterilization, Equipment Sterilization, ETO Sterilization, Filtration Sterilization, Gamma Sterilization, Radiation Sterilization, and Steam Sterilization.
  • Based on End-User, market is studied across Food & Beverage Companies, Hospitals & Clinics, Life Sciences Industry, Medical Device Companies, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising incidence of hospital-acquired infections and surging usage of infection control products
      • 5.1.1.2. Increasing number of surgical procedures and need for appropriate safety methods
      • 5.1.1.3. Upsurging adoption of infection control products in medical device and pharmaceutical industry
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse effects associated with chemical based disinfectants
    • 5.1.3. Opportunities
      • 5.1.3.1. Increasing outsourcing of sterilization services by hospitals, and clinics
      • 5.1.3.2. Growing investments by manufacturers in the production of infection control products
    • 5.1.4. Challenges
      • 5.1.4.1. Availability of substitute products and techniques for infection control
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Products: Burgeoning usage of sterilization eliminate all forms of microbial life, including spores to ensure the safety of medical devices
    • 5.2.2. End-User: Evolving usage of infection control in hospitals & clinics sector
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Infection Control Market, by Transmission

  • 6.1. Introduction
  • 6.2. Airborne
  • 6.3. Bloodborne
  • 6.4. Contract

7. Infection Control Market, by Products

  • 7.1. Introduction
  • 7.2. Cleaning & Disinfection
    • 7.2.1. Disinfectants
      • 7.2.1.1. Hand Disinfectants
      • 7.2.1.2. Instrument Disinfectants
      • 7.2.1.3. Skin Disinfectants
      • 7.2.1.4. Surface Disinfectants
    • 7.2.2. Equipment
      • 7.2.2.1. Flusher Disinfectors
      • 7.2.2.2. Ultrasonic Cleaners
      • 7.2.2.3. UV-Ray Disinfectors
      • 7.2.2.4. Washer Disinfectors
    • 7.2.3. Formulation
      • 7.2.3.1. Disinfectant Sprays
      • 7.2.3.2. Disinfectant Wipes
      • 7.2.3.3. Liquid Disinfectants
    • 7.2.4. Level of Disinfection
      • 7.2.4.1. High-Level
      • 7.2.4.2. Intermediate-Level
      • 7.2.4.3. Low-Level
  • 7.3. Endoscope Reprocessing
    • 7.3.1. Consumables
    • 7.3.2. Equipment
  • 7.4. Protective Barriers
    • 7.4.1. Covers & Closures
    • 7.4.2. Goggles
    • 7.4.3. Medical Nonwovens
  • 7.5. Sterilization
    • 7.5.1. E-Beam Sterilization
    • 7.5.2. Equipment Sterilization
    • 7.5.3. ETO Sterilization
    • 7.5.4. Filtration Sterilization
    • 7.5.5. Gamma Sterilization
    • 7.5.6. Radiation Sterilization
    • 7.5.7. Steam Sterilization

8. Infection Control Market, by End-User

  • 8.1. Introduction
  • 8.2. Food & Beverage Companies
  • 8.3. Hospitals & Clinics
  • 8.4. Life Sciences Industry
  • 8.5. Medical Device Companies
  • 8.6. Pharmaceutical Companies

9. Americas Infection Control Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Infection Control Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Infection Control Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Freudenberg Medical Establishes Second Production Facility In Costa Rica
    • 12.3.2. WPT Nonwovens Invests USD 19.5M in Kentucky Manufacturing Facility, Boosting Local Economy
    • 12.3.3. Berry Launches Lightweight Tube Closure Solution Catering To The Stringent Safety And Hygiene Standards Mandated In Infection Control Protocols
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Abbott Laboratories
  • 3. AliMed, Inc.
  • 4. Amway Corporation
  • 5. Ansell Ltd.
  • 6. ASP International GmbH
  • 7. Becton, Dickinson and Company
  • 8. Belimed AG
  • 9. bioMerieux SA
  • 10. Cantel Medical Group
  • 11. Cardinal Health Inc.
  • 12. Codi Group BV
  • 13. Colgate-Palmolive Company
  • 14. Dandong Huayang Textile and Garment Co., Ltd.
  • 15. Diversey Holdings Ltd.
  • 16. Ecolab Corporation
  • 17. Embuer Health Pvt. Ltd.
  • 18. Essity AB
  • 19. F. Hoffmann-La Roche Ltd.
  • 20. Getinge AB
  • 21. Go Green Solutions, LLC
  • 22. GOJO Industries, Inc.
  • 23. Hartmann Group
  • 24. Jiaxing Hongjie Commodity Co., Ltd.
  • 25. Kao Corporation
  • 26. Kimberly-Clark Corporation
  • 27. Matachana Group
  • 28. Medexter Healthcare GmbH
  • 29. Medline Industries, LP
  • 30. MELAG Medizintechnik GmbH & Co. KG
  • 31. Merck KGaA
  • 32. Metrex Research, LLC
  • 33. Nice-Pak Products, Inc.
  • 34. Olympus Corporation
  • 35. Pal International Ltd.
  • 36. Pfizer Inc.
  • 37. Procter & Gamble Company
  • 38. Professional Disposables International, Inc.
  • 39. Reckitt Benckiser Group PLC
  • 40. Rockline Industries Ltd.
  • 41. S. C. Johnson & Son, Inc.
  • 42. Sotera Health LLC
  • 43. Sterigenics International LLC
  • 44. Steris Corporation
  • 45. Unicharm Corporation
  • 46. Unilever PLC
  • 47. Weiman Products, LLC
  • 48. World Precision Instruments, LLC
  • 49. Yessor Wipes

LIST OF FIGURES

  • FIGURE 1. INFECTION CONTROL MARKET RESEARCH PROCESS
  • FIGURE 2. INFECTION CONTROL MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INFECTION CONTROL MARKET DYNAMICS
  • TABLE 7. GLOBAL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INFECTION CONTROL MARKET SIZE, BY AIRBORNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INFECTION CONTROL MARKET SIZE, BY BLOODBORNE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONTRACT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INFECTION CONTROL MARKET SIZE, BY HAND DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INFECTION CONTROL MARKET SIZE, BY INSTRUMENT DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INFECTION CONTROL MARKET SIZE, BY SKIN DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INFECTION CONTROL MARKET SIZE, BY SURFACE DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL INFECTION CONTROL MARKET SIZE, BY FLUSHER DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL INFECTION CONTROL MARKET SIZE, BY ULTRASONIC CLEANERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL INFECTION CONTROL MARKET SIZE, BY UV-RAY DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL INFECTION CONTROL MARKET SIZE, BY WASHER DISINFECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL INFECTION CONTROL MARKET SIZE, BY DISINFECTANT WIPES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIQUID DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL INFECTION CONTROL MARKET SIZE, BY HIGH-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL INFECTION CONTROL MARKET SIZE, BY INTERMEDIATE-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL INFECTION CONTROL MARKET SIZE, BY LOW-LEVEL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL INFECTION CONTROL MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL INFECTION CONTROL MARKET SIZE, BY COVERS & CLOSURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL INFECTION CONTROL MARKET SIZE, BY GOGGLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL NONWOVENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL INFECTION CONTROL MARKET SIZE, BY E-BEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL INFECTION CONTROL MARKET SIZE, BY ETO STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL INFECTION CONTROL MARKET SIZE, BY FILTRATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL INFECTION CONTROL MARKET SIZE, BY GAMMA STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL INFECTION CONTROL MARKET SIZE, BY RADIATION STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL INFECTION CONTROL MARKET SIZE, BY STEAM STERILIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL INFECTION CONTROL MARKET SIZE, BY FOOD & BEVERAGE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL INFECTION CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL INFECTION CONTROL MARKET SIZE, BY LIFE SCIENCES INDUSTRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL INFECTION CONTROL MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL INFECTION CONTROL MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 69. AMERICAS INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 70. AMERICAS INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. AMERICAS INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 96. CANADA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 107. MEXICO INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 108. MEXICO INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 109. MEXICO INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 110. MEXICO INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 119. UNITED STATES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 120. UNITED STATES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 121. UNITED STATES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 122. UNITED STATES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 123. UNITED STATES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 124. UNITED STATES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 142. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 143. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 144. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 145. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 146. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 147. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 148. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 149. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 150. AUSTRALIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 153. CHINA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 154. CHINA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 155. CHINA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 156. CHINA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 157. CHINA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 158. CHINA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 159. CHINA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 160. CHINA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 161. CHINA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 164. INDIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 165. INDIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 166. INDIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 167. INDIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 168. INDIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 169. INDIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 170. INDIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 171. INDIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 172. INDIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 175. INDONESIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 176. INDONESIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 177. INDONESIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 178. INDONESIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 179. INDONESIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 180. INDONESIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 181. INDONESIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 182. INDONESIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 183. INDONESIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 186. JAPAN INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 187. JAPAN INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 188. JAPAN INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 189. JAPAN INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 190. JAPAN INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 191. JAPAN INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 192. JAPAN INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 193. JAPAN INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 194. JAPAN INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 197. MALAYSIA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 198. MALAYSIA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 199. MALAYSIA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 200. MALAYSIA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 201. MALAYSIA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 202. MALAYSIA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 203. MALAYSIA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 204. MALAYSIA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 205. MALAYSIA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 208. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 209. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 210. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 211. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 212. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 213. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 214. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 215. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 216. PHILIPPINES INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 219. SINGAPORE INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 220. SINGAPORE INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 221. SINGAPORE INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 222. SINGAPORE INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 223. SINGAPORE INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 224. SINGAPORE INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 225. SINGAPORE INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 226. SINGAPORE INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 227. SINGAPORE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 230. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 231. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 232. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 233. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 234. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 235. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 236. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 237. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 238. SOUTH KOREA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 241. TAIWAN INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 242. TAIWAN INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 243. TAIWAN INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 244. TAIWAN INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 245. TAIWAN INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 246. TAIWAN INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 247. TAIWAN INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 248. TAIWAN INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 249. TAIWAN INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 252. THAILAND INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 253. THAILAND INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 254. THAILAND INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 255. THAILAND INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 256. THAILAND INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 257. THAILAND INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 258. THAILAND INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 259. THAILAND INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 260. THAILAND INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 263. VIETNAM INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 264. VIETNAM INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 265. VIETNAM INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 266. VIETNAM INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 267. VIETNAM INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 268. VIETNAM INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 269. VIETNAM INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 270. VIETNAM INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 271. VIETNAM INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 275. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 276. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 277. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 278. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 279. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 280. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 281. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 282. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 283. EUROPE, MIDDLE EAST & AFRICA INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 286. DENMARK INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 287. DENMARK INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 288. DENMARK INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 289. DENMARK INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 290. DENMARK INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 291. DENMARK INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 292. DENMARK INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 293. DENMARK INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 294. DENMARK INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 297. EGYPT INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 298. EGYPT INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 299. EGYPT INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 300. EGYPT INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 301. EGYPT INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 302. EGYPT INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 303. EGYPT INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 304. EGYPT INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 305. EGYPT INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 307. FINLAND INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 308. FINLAND INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 309. FINLAND INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 310. FINLAND INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 311. FINLAND INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 312. FINLAND INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 313. FINLAND INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 314. FINLAND INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 315. FINLAND INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 316. FINLAND INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 317. FRANCE INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 318. FRANCE INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 319. FRANCE INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 320. FRANCE INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 321. FRANCE INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 322. FRANCE INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 323. FRANCE INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 324. FRANCE INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 325. FRANCE INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 326. FRANCE INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 327. FRANCE INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 328. GERMANY INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 329. GERMANY INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 330. GERMANY INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 331. GERMANY INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 332. GERMANY INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 333. GERMANY INFECTION CONTROL MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 334. GERMANY INFECTION CONTROL MARKET SIZE, BY LEVEL OF DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 335. GERMANY INFECTION CONTROL MARKET SIZE, BY ENDOSCOPE REPROCESSING, 2018-2030 (USD MILLION)
  • TABLE 336. GERMANY INFECTION CONTROL MARKET SIZE, BY PROTECTIVE BARRIERS, 2018-2030 (USD MILLION)
  • TABLE 337. GERMANY INFECTION CONTROL MARKET SIZE, BY STERILIZATION, 2018-2030 (USD MILLION)
  • TABLE 338. GERMANY INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 339. ISRAEL INFECTION CONTROL MARKET SIZE, BY TRANSMISSION, 2018-2030 (USD MILLION)
  • TABLE 340. ISRAEL INFECTION CONTROL MARKET SIZE, BY PRODUCTS, 2018-2030 (USD MILLION)
  • TABLE 341. ISRAEL INFECTION CONTROL MARKET SIZE, BY CLEANING & DISINFECTION, 2018-2030 (USD MILLION)
  • TABLE 342. ISRAEL INFECTION CONTROL MARKET SIZE, BY DISINFECTANTS, 2018-2030 (USD MILLION)
  • TABLE 343. ISRAEL INFECTION CONTROL MARKET SIZE, BY EQUIPMENT, 2018-2030 (USD MILLION)
  • TABLE 344. ISRAEL INFECTION CONTROL M